KYG0477L1005 - Common Stock
ARCTOS NORTHSTAR ACQUISIT-A
NYSE:ANAC (2/24/2023, 7:13:21 PM)
10.19
+0 (+0.05%)
Arctos NorthStar Acquisition Corp. operates as a blank check company. The company is headquartered in Dallas, Texas. The company went IPO on 2021-02-23. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm may pursue an acquisition opportunity in any industry or sector and intends to pursue opportunities in the sports, media and entertainment sectors. Within the broader sports, media and entertainment sectors, it intends to focus on certain sub-sectors including but not limited to sports teams, leagues, data and technology, digital infrastructure, health & wellness, e-sports, betting, ticketing, agencies, services and hospitality.
ARCTOS NORTHSTAR ACQUISIT-A
2021 Mckinney Avenue, Suite 200, Suite 200
Dallas TEXAS 94303
P: 19729183800.0
CEO: Theo Epstein
Employees: 0
Website: https://www.arctosnorthstar.com/
Immune Pharmaceuticals is gearing up for its split into two pure play companies with new patent filings, strategic deals for commercialization, and the initiation of new clinical trials to support its wide-ranging pipeline.
Here you can normally see the latest stock twits on ANAC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: